Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

NCT06492304

Conditions
Acute Myeloid Leukemia, B Cell Lymphoma, Hematologic Diseases, +15 more
Locations
  • Research Site 6 Phoenix, Arizona, United States
  • Research Site 5 Stanford, California, United States
  • Research Site 3 Boston, Massachusetts, United States
  • Research Site 4 New York, United States
View Trial Details
Completed

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

NCT00428142

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada
View all 19 locations
View Trial Details
Completed

Controlling Hypertension Through Education and Coaching in Kidney Disease

NCT04087798

Conditions
Cardiovascular Diseases, Chronic Disease, Chronic Kidney Disease Stage 5, +26 more
Locations
  • University of Michigan / Domino's Farms Ann Arbor, Michigan, United States
  • University of Michigan / Briarwood Family Medicine Ann Arbor, Michigan, United States
  • University of Michigan / Brighton Health Center Brighton, Michigan, United States
  • University of Michigan / Canton Health Center Canton, Michigan, United States
View Trial Details
Completed

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

NCT01846390

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details

Related conditions